Our programs
Deep expertise in medicinal chemistry combined with our AI-powered discovery and translational platform accelerates the creation of our novel precision psychiatric therapies.
NMDAR Antagonist
Orally bioavailable
Rapid-acting
Fewer dissociative effects
Depression and other indications
New Chemical Entity
5-HT2AR Agonists
Rapid acting anti-depressants
Optimized duration of effect
Improved cardiac safety profile
Depression and other indications
New Chemical Entities
Non-Hallucinogenic Neuroplastogens
Rapid acting
Orally bioavailable
Non-Hallucinogenic
Depression and other indications
New Chemical Entities
Safer Ibogaine Analogs
Rapid and sustained efficacy
Improved cardiac safety profile
Opioid use disorder and other indications
New Chemical Entity
